MLYS NASDAQ
Mineralys Therapeutics, Inc.
1W: -8.6%
1M: -18.6%
3M: -18.9%
YTD: -33.8%
1Y: -40.6%
3Y: +139.9%
$23.63
-0.09 (-0.38%)
Weekly Expected Move ±9.1%
$19
$21
$24
$26
$28
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-350M
Net Income
-83.2% YoY
$-139M
Free Cash Flow
+28.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-80.9%
ROA-69.7%
ROIC2274.6%
Valuation
P/E-5.6
P/B3.6
EV/EBITDA-4.9
Leverage
Debt/Equity0.18
Current Ratio34.46
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z9.62
Beneish M0.00